Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slivka, A.
Right arrow Articles by Pulsinelli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slivka, A.
Right arrow Articles by Pulsinelli, W.

Stroke, Vol 21, 808-811, Copyright © 1990 by American Heart Association


ARTICLES

Carnitine treatment for stroke in rats

A Slivka, D Silbersweig and W Pulsinelli
Department of Neurology, Cornell University Medical College, New York, New York.

Changes in the concentrations of carnitine, long-chain acylcoenzyme A, and long-chain acylcarnitine in ischemic myocardium parallel those in ischemic brain. Since carnitine treatment reverses these changes and improves function in ischemic hearts, we examined whether carnitine given to rats before focal cerebral ischemia (produced by tandem right common carotid artery and middle cerebral artery occlusion) alters infarct volume in four separate experiments. Mannitol was used to control for the osmotic effect of carnitine on brain edema in one experiment. While carnitine was found to significantly decrease infarct volume compared with saline in one experiment (p less than 0.05, Student's t test), this result could not be replicated in the subsequent three experiments. Because the positive treatment effect was not reproducible despite similar experimental conditions, the result of the first experiment was attributed to a type I error. Mannitol also showed no significant effect on infarct volume. This study emphasizes the need for concurrent controls with each group of treated animals and the need for replicating the results of a single experiment when testing for drug efficacy in animal models of focal cerebral ischemia.


This article has been cited by other articles:


Home page
StrokeHome page
S. Khanna, S. Roy, A. Slivka, T. K.S. Craft, S. Chaki, C. Rink, M. A. Notestine, A. C. DeVries, N. L. Parinandi, and C. K. Sen
Neuroprotective Properties of the Natural Vitamin E {alpha}-Tocotrienol
Stroke, October 1, 2005; 36(10): e144 - e152.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Bereczki, M. Liu, G. F. d. Prado, and I. Fekete
Cochrane Report : A Systematic Review of Mannitol Therapy for Acute Ischemic Stroke and Cerebral Parenchymal Hemorrhage
Stroke, November 1, 2000; 31(11): 2719 - 2722.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Slivka, E. Murphy, and L. Horrocks
Cerebral Edema After Temporary and Permanent Middle Cerebral Artery Occlusion in the Rat
Stroke, June 1, 1995; 26(6): 1061 - 1066.
[Abstract] [Full Text]